PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.
Published December 9, 2015 · Recall initiated: October 26, 2015
Summary
FDA records medical device Class II recall Z-0368-2016, published December 9, 2015 and initiated October 26, 2015. Recalling firm: Merz North America, Inc.; Status: Terminated; Reported quantity: 9,439 units; Lot: Lot Number 100076901, 100077013, 100077249, 100077250, 100078691, 100079054, 100079213, 100079597, 100079954, 100080082, 100081008, 100081401, 100081573, 100081916, 100082248, 100082468, 100082695, 100082729, 100083126, 100083785, 100083934. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Merz North America, Inc.
- Distributor
- Distributed US (nationwide) including the Virgin Islands and South Africa.
- Lot
- Lot Number 100076901, 100077013, 100077249, 100077250, 100078691, 100079054, 100079213, 100079597, 100079954, 100080082, 100081008, 100081401, 100081573, 100081916, 100082248, 100082468, 100082695, 100082729, 100083126, 100083785, 100083934
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDARadiesse (+) Lidocaine, Injectable Implant 1.5cc, Rx only, P/N: 8063M0K1, Merz Aesthetics. Product Usage:August 31, 2016
- FDAMECLIZINE HYDROCHLORIDE TABLETS, 25 mg, Packaged in a) 100 ct Bottles (NDC: 60429-205-01) and b) 1000 ctDecember 16, 2015
- FDABicillin L-A 600000 Units/mL Inj., Qty: 20 mL Syringe, MFG by: King Pharma Inc., Bristol, TN 37620, RepackagedDecember 16, 2015
- FDAU-SDN 2 Part Ultra Modified Seldinger Needles, NS/37-0387. All needles were sold in bulk, non-sterile, andDecember 9, 2015
- FDAPhilips Healthcare Xper vascular systems R7.6 Model : 722134 Product Usage: The Allura Xper series is intendedDecember 9, 2015
- FDAPhilips Healthcare INTEGRIS H5000F/Allura 9F Model : 722017 Product Usage: The Allura Xper series is intendedDecember 9, 2015
Questions about this recall
Was PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency. recalled?
Yes. FDA published recall Z-0368-2016 on December 9, 2015. Reported hazard: The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
What should I do if I have this product?
Voluntary: Firm initiated · Letter